Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | USP2 | O75604 | 4/20 | 0.59 |
| ▸ | POLB | P06746 | 3/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | PLEC | Q15149 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.51 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | TNKS | O95271 | 1/20 | 0.51 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | ALPG | P10696 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16808265 | 0.92 | ALDH1A1 (0.51) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL12909301 | 0.89 | USP2 (0.68) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL12909292 | 0.89 | MEN1 (0.59) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL18504843 | 0.88 | MAOB (0.49) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL12909289 | 0.88 | MEN1 (0.59) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL4737221 | 0.86 | USP2 (0.56) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL10167876 | 0.86 | MEN1 (0.72) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL10030600 | 0.86 | USP2 (0.64) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL12909304 | 0.86 | USP2 (0.51) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL12909302 | 0.85 | USP2 (0.53) | MEN1KMT2AUSP2POLBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11519014-B2 | Specific substrate of an ALDH isoenzyme | ADVANCED BIODESIGN (FR) | 2022-12-06 | — | — | US | disclosed |
| US-11519014-B2 | Specific substrate of an ALDH isoenzyme | ADVANCED BIODESIGN (FR) | 2022-12-06 | — | — | US | disclosed |
| US-20210017594-A1 | METHODS FOR OBTAINING AND CORRECTING BIOLOGICAL SEQUENCE INFORMATION | CYGNUS BIOSCIENCES (BEIJING) CO., LTD. (CN) | 2021-01-21 | — | — | US | disclosed |
| US-20200407787-A1 | METHODS FOR OBTAINING AND CORRECTING BIOLOGICAL SEQUENCE INFORMATION | CYGNUS BIOSCIENCES (BEIJING) CO., LTD (CN) | 2020-12-31 | — | — | US | disclosed |
| US-10738356-B2 | Methods for obtaining and correcting biological sequence information | CYGNUS BIOSCIENCES (BEIJING) CO., LTD. (CN) | 2020-08-11 | — | — | US | disclosed |
| US-10370538-B2 | Probes for rapid and specific detection of mycobacteria | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2019-08-06 | — | — | US | disclosed |
| US-20190233871-A1 | SPECIFIC SUBSTRATE OF AN ALDH ISOENZYME | ADVANCED BIODESIGN (FR) | 2019-08-01 | — | — | US | disclosed |
| US-20190233871-A1 | SPECIFIC SUBSTRATE OF AN ALDH ISOENZYME | ADVANCED BIODESIGN (FR) | 2019-08-01 | — | — | US | disclosed |
| EP-3491143-A1 | SPECIFIC SUBSTRATE OF AN ALDH ISOENZYME | Advanced Biodesign (FR) | 2019-06-05 | — | — | EP | disclosed |
| US-20180305329-A1 | XANTHINE COMPOUND AND USE THEREOF | GORYO CHEMICAL, INC. (JP) | 2018-10-25 | — | — | US | disclosed |
| US-7868147-B2 | substantially no fluorescent before the cleavage but highly fluorescent after the cleavage; traps a target substance such as an enzyme and emits fluorescence | Nagano, Tetsuo (JP) | 2011-01-11 | — | — | US | disclosed |
| US-7868147-B2 | substantially no fluorescent before the cleavage but highly fluorescent after the cleavage; traps a target substance such as an enzyme and emits fluorescence | Nagano, Tetsuo (JP) | 2011-01-11 | — | — | US | disclosed |
| US-7842823-B2 | Fluorogenic probes for reactive oxygen species | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-11-30 | — | — | US | disclosed |
| US-20100297681-A1 | FLUORESCENT PROBE FOR MEASUREMENT OF GLUCURONATE TRANSFERASE | THE UNIVERSITY OF TOKYO (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20100297681-A1 | FLUORESCENT PROBE FOR MEASUREMENT OF GLUCURONATE TRANSFERASE | THE UNIVERSITY OF TOKYO (JP) | 2010-11-25 | — | — | US | disclosed |
| US-7524974-B2 | Fluorescent probe | Nagano, Tetsuo (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7524974-B2 | Fluorescent probe | Nagano, Tetsuo (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20080014602-A1 | Fluorescent Probe | SEKISUI MEDICAL CO., LTD. (JP) | 2008-01-17 | — | — | US | disclosed |
| US-20080014602-A1 | Fluorescent Probe | SEKISUI MEDICAL CO., LTD. (JP) | 2008-01-17 | — | — | US | disclosed |
| US-20070141658-A1 | Fluorogenic probes for reactive oxygen species | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070141658-A1 | Fluorogenic probes for reactive oxygen species | PRDX1, GPX1, GPX4 | MEN1 2037/4885KMT2A 4358/4885USP2 2291/4885 |
| US-10370538-B2 | Probes for rapid and specific detection of mycobacteria | DPEP1, MRPL21, RCE1 | MEN1 4202/4885KMT2A 4233/4885USP2 362/4885 |
| US-20180305329-A1 | XANTHINE COMPOUND AND USE THEREOF | CYP3A43, CYP3A4, CYP1A1 | MEN1 4859/4885KMT2A 4199/4885USP2 1995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.